You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19
|
---|---|
Published in |
Frontiers in immunology, April 2022
|
DOI | 10.3389/fimmu.2022.868020 |
Pubmed ID | |
Authors |
Valentina Mazzotta, Alessandro Cozzi-Lepri, Francesca Colavita, Simone Lanini, Silvia Rosati, Eleonora Lalle, Ilaria Mastrorosa, Claudia Cimaglia, Alessandra Vergori, Nazario Bevilacqua, Daniele Lapa, Andrea Mariano, Aurora Bettini, Chiara Agrati, Pierluca Piselli, Enrico Girardi, Concetta Castilletti, Anna Rosa Garbuglia, Francesco Vaia, Emanuele Nicastri, Andrea Antinori |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 27 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 6 | 22% |
Student > Bachelor | 3 | 11% |
Unspecified | 2 | 7% |
Student > Master | 2 | 7% |
Researcher | 2 | 7% |
Other | 1 | 4% |
Unknown | 11 | 41% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 3 | 11% |
Unspecified | 2 | 7% |
Environmental Science | 2 | 7% |
Business, Management and Accounting | 1 | 4% |
Nursing and Health Professions | 1 | 4% |
Other | 5 | 19% |
Unknown | 13 | 48% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2022.
All research outputs
#16,734,944
of 25,392,582 outputs
Outputs from Frontiers in immunology
#18,355
of 31,549 outputs
Outputs of similar age
#250,036
of 445,322 outputs
Outputs of similar age from Frontiers in immunology
#1,016
of 1,694 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 31,549 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,322 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,694 others from the same source and published within six weeks on either side of this one. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.